-
Views
-
Cite
Cite
Robert John Wilkinson, Hans Martin Vordermeier, Katalin Andrea Wilkinson, Ann Sjölund, Carlos Moreno, Geoffrey Pasvol, Juraj Ivanyi, Peptide-Specific T Cell Response to Mycobacterium tuberculosis: Clinical Spectrum, Compartmentalization, and Effect of Chemotherapy, The Journal of Infectious Diseases, Volume 178, Issue 3, September 1998, Pages 760–768, https://doi.org/10.1086/515336
- Share Icon Share
Abstract
The T cell repertoire of 59 patients with untreated tuberculosis was compared with that of 46 bacille Calmette-Guérin-vaccinated controls by assaying the proliferative responses to six permissively recognized peptides from the 16-, 19-, and 38-kDa molecules of Mycobacterium tuberculosis. A trend from higher to lower reactivity following this order: vaccinated controls > lymph node disease > localized extrapulmonary > pulmonary > pleural was seen for 4 of the peptides (P < .03). The decreased response of blood lymphocytes from patients with pleural tuberculosis was partially accounted for by sequestration of peptide-responsive cells within the pleural fluid. Chemotherapy “reversed” the depressed proliferative responses of patients with pulmonary and pleu tuberculosis depending on the peptide origin, being greatest for peptides of 16 kDa, transient for those of 19 kDa, and least for those of 38 kDa. These data demonstrate antigen specificity in the decreased responsiveness of patients with tuberculosis.